Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-09-02

FDA Approved: TELMISARTAN AND AMLODIPINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for a generic fixed-dose combination of telmisartan and amlodipine for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan and Amlodipine (Telmisartan and Amlodipine)

Snippet

SUPPL AP for TELMISARTAN AND AMLODIPINE (TELMISARTAN AND AMLODIPINE)